Your browser doesn't support javascript.
loading
Advance on Chinese Medicine for Hypertensive Renal Damage: Focus on the Complex Molecular Mechanisms.
Lu, Yan; Xie, Xue-Na; Xin, Qi-Qi; Yuan, Rong; Miao, Yu; Cong, Wei-Hong; Chen, Ke-Ji.
Affiliation
  • Lu Y; Laboratory of Cardiovascular Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100091, China.
  • Xie XN; School of Pharmacy, Macau University of Science and Technology, Taipa, Macau, 999078, China.
  • Xin QQ; Laboratory of Cardiovascular Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100091, China.
  • Yuan R; National Clinical Research Center for Chinese Medicine Cardiology, Beijing, 100091, China.
  • Miao Y; Laboratory of Cardiovascular Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100091, China.
  • Cong WH; National Clinical Research Center for Chinese Medicine Cardiology, Beijing, 100091, China.
  • Chen KJ; Laboratory of Cardiovascular Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, 100091, China.
Chin J Integr Med ; 2024 Jul 03.
Article de En | MEDLINE | ID: mdl-38958884
ABSTRACT
Hypertensive renal damage (HRD) is a major cause of end-stage renal disease. Among the causes of end-stage renal disease, HRD accounts for nearly 34% of the total number of cases. Antihypertensive treatment is primarily drug-based, but therapeutic efficacy is less effective and can have serious side effects. Chinese medicine (CM) has significant advantages in the treatment of HRD. CM is rich in various active ingredients and has the property of targeting multiple targets and channels. Therefore, the regulatory network of CM on disease is complex. A large number of CM have been employed to treat HRD, either as single applications or as part of compound formulations. The key possible mechanisms of CM for HRD include regulation of the renin-angiotensin-aldosterone system, antioxidation, anti-inflammation, rescue of endothelial function, regulation of vasoactive substance secretion and obesity-related factors, etc. This review summarized and discussed the recent advance in the basic research mechanisms of CM interventions for HRD and pointed out the challenges and future prospects.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Chin J Integr Med Sujet du journal: TERAPIAS COMPLEMENTARES Année: 2024 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Chin J Integr Med Sujet du journal: TERAPIAS COMPLEMENTARES Année: 2024 Type de document: Article Pays d'affiliation: Chine